No, it is not free market economics for an entire country to negotiate a single price. How would you distinguish that from Communism, where a central bureaucracy sets prices? Free markets refers to delegating purchase decisions to as low a level as possible, so that the prices are as close to weighted averages of individual preferences as possible. In a free market, there would be continuous supply and demand curves. If the price of Gleevac were $40,000 per person per year, there would still be significant demand for it in the UK. The way it is now, the government forces demand to be zero.
Well for a start, you need to be aware that each of the UK home nations have different versions of NHS, which in turn take their own views on costs.
So, for example, the Scottish Medicines Consortium uses the Detailed Advice Document as a basis for comparison between competitor products . In England (and I suspect Wales) there are seperate negotiating instruments which it think involve both statutory and voluntary schemes.
On that basis, it is already being deal with at a comparatively local level. Moreover in terms of "customer base", NHS Scotland only deals with some 5.5m people. I would suggest to you that this is likely to be of an order comparable to private sector purchasers (i.e. healthcare insurers) in the US.
You also overlook the fact that there is a seperate private sector health industry here in the UK which would not be subject to any restrictions imposed by negotiation (or statute, if that were the way of it) re: the NHS.
Incidentally Imatinib (Glivec) is accepted for restricted use within NHS Scotland. I have no idea about England as I don't live there.
Last edited: